A retrospective analysis of the therapeutic effects of 0.01% atropine on axial length growth in children in a real-life clinical setting.

Graefes Arch Clin Exp Ophthalmol · 2021 · PMC8478763 · PMID 34142186

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Different from large RCTs where 0.01% atropine eye drops caused a highly significant inhibition of myopic progression (i.e., ATOM2 study, LAMP study), our study showed an inhibitory effect only on axial lengths and not on spherical equivalents.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.